1McCullough, ML, Weinstein, SJ, Freedman, DM, et al. (2010) Correlates of circulating 25-hydroxyvitamin D: cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 172, 21–35.
2Trump, DL, Chadha, MK, Sunga, AY, et al. (2009) Vitamin D deficiency and insufficiency among patients with prostate cancer. BRU Int 104, 909–914.
3Bertone-Johnson, ER, Chen, WY, Holich, MF, et al. (2005) Plasma 25-hydroxyvitamin D and 1,25 dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14, 1991–1997.
4Ng, K, Meyerhardt, JA, Wu, K, et al. (2008) Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 26, 2984–2991.
5Gorham, ED, Garland, CF, Garland, FC, et al. (2005) Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 97, 179–194.
6Abbas, S, Linseisen, J, Slanger, T, et al. (2007) Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer – results of a large case–control study. Carcinogenesis 29, 93–99.
7Yin, L, Grandi, N, Raum, E, et al. (2009) Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 30, 113–125.
8Deeb, KK, Trump, DL & Johnson, CS (2007) Vitamin D signaling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7, 684–700.
9Welsh, J (2004) Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr 80, Suppl. 6, 1721S–1724S.
10Rassnick, KM, Muindi, JR, Johnson, CS, et al. (2008) In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors. Cancer Chemother Pharmacol 62, 881–891.
11How, KL, Hazewinkel, HA & Mol, JA (1994) Dietary vitamin D dependence of cat and dog due to inadequate cutaneous synthesis of vitamin D. Gen Comp Endocrinol 96, 12–18.
12Dorn, CR, Taylor, DO, Schneider, R, et al. (1968) Survey of animal neoplasms in Alameda and Contra Costa Counties. California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 40, 307–318.
13Cohen, D, Reif, JS, Brodey, RS, et al. (1974) Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res 34, 2859–2868.
14Rassnick, KM, Moore, AS, Williams, LE, et al. (1999) Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 13, 601–605.
15Rassnick, KM, Bailey, DB, Flory, AB, et al. (2008) Efficacy of vinblastine for treatment of canine mast cell tumors. J Vet Intern Med 22, 1390–1396.
16Russell, DS, Rassnick, KM, Erb, HN, et al. (2010) An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours. J Comp Pathol 143, 223–226.
17Malone, EK, Rassnick, KM, Wakshlag, JJ, et al. (2010) Calcitriol enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in-vitro and has single agent activity against spontaneously occurring canine mast cell tumours. Vet Comp Oncol 8, 209–220.
18Chapuy, MC, Preziosi, P, Maamer, M, et al. (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7, 439–444.
19Krall, EA, Sahyoun, N, Tannenbaum, S, et al. (1989) Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women. N Engl J Med 321, 1777–1783.
20Giovannucci, E (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16, 83–95.